Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AGNPF

Recent news which mentions AGNPF

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Tickers AGNPF ATAI CMND CMPS
Tags ATAI Benzinga Psychedelics Podcast Biotech
From Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
Tickers AGNPF
Tags Psychedelics Market News Human Stroke
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Tickers AGNPF ATAI AWKNF CMPS
Tags SILFF Global CYBN
From Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
Tickers AGNPF
Tags Algernon NeuroScience News AGNPF
From Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
Tickers AGNPF
Tags Market News Human Stroke AGN Neuro
From Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
Tickers AGNPF CMND PSYGF
Tags Markets Benzinga Market News
From Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
Tickers AGNPF
Tags Psychedelics Psychedelic/Assisted Therapies Markets
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Tickers AGNPF AWKNF BRAXF CMPS
Tags Benzinga FTHWF Psychedelic/Assisted Therapies
From Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
Tickers AGNPF
Tags Benzinga contributors Market News
From Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
Tickers AGNPF IPOS
Tags Benzinga Markets Psychedelics
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Tickers AGNPF AWKNF CMND CYBN
Tags Management Sector ETFs SPRC
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Tickers AGNPF AWKNF CYBN DMTTF
Tags Earnings Psychedelics Reform Psychedelics Investing
From Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
Tickers AGNPF TBI
Tags Penny Stocks Health Care Psychedelics
From Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
Tickers AGNPF
Tags Cannabis General Human Stroke
From Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
Tickers AGNPF DMT
Tags Cannabis Market News Human Stroke
From Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
Tickers AGNPF
Tags Markets Benzinga Psychedelics
From Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Tickers AGNPF ATAI FLHLF
Tags Management Benjamin Lightburn Markets
From Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Tickers AGNPF BMNDF CMND CMPS
Tags BMNDF Benzinga Psychedelics
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Tickers AGNPF
Tags Psychedelics Market News Markets
From Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
Tickers AGNPF
Tags Psychedelics depression Markets
From Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
Tickers AGNPF DMT
Tags News AGNPF Legal
From Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
Tickers AGNPF
Tags Management DMT Analogue Centre for Human Drug Research
From Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
Tickers AGNPF
Tags Market News Cannabis AlphaNorth Asset Management
From Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
Tickers AGNPF
Tags Biotech AGNPF News
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Tickers AGNPF ALID ATAI AWKNF
Tags LMLLF ENTBF NVMDF
From Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Tickers AGNPF ALID ATAI AWKNF
Tags MYNDF NMLSF Market News
From Benzinga
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
Tickers AGNPF ALID ATAI FTRP
Tags Benzinga Markets Penny Stocks
From Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
Tickers AGNPF ATOS GILD LLY
Tags GILD NASDAQ:ATOS, NYSE:LLY,OTC:AGNPF,NASDAQ:SRNE,NASDAQ:GILD AGNPF
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.